2017
Aspirin Use and Reduced Risk of Pancreatic Cancer
Risch HA, Lu L, Streicher SA, Wang J, Zhang W, Ni Q, Kidd MS, Yu H, Gao YT. Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiology Biomarkers & Prevention 2017, 26: 68-74. PMID: 27999143, PMCID: PMC5225096, DOI: 10.1158/1055-9965.epi-16-0508.Peer-Reviewed Original ResearchConceptsPancreatic cancerAspirin useRegular useConfidence intervalsLong-term aspirin useControl subjects frequencyLow-dose aspirinAvoidance of smokingBody mass indexPopulation-based studyUnconditional logistic regressionABO blood groupRisk-benefit analysisAspirin typeCagA seropositivityDiabetes mellitusMass indexCigarette smokingCardiovascular diseaseAspirinCancerCertain cancersLogistic regressionBlood groupSubjects frequency
2010
Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium
Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, Ward MH, Giffen C, Casson AG, Abnet CC, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow WH. Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium. Journal Of The National Cancer Institute 2010, 102: 1344-1353. PMID: 20716718, PMCID: PMC2935475, DOI: 10.1093/jnci/djq289.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaDose-Response Relationship, DrugEsophageal NeoplasmsEsophagogastric JunctionFemaleHumansIncidenceMaleResearch DesignRisk FactorsSmokingSmoking CessationStomach NeoplasmsTime FactorsConceptsSummary odds ratiosRisk of adenocarcinomaCigarette smokingSmoking cessationOdds ratioEsophagogastric junctional adenocarcinomaEsophagogastric junctionJunctional adenocarcinomaEsophageal adenocarcinomaPopulation-based case-control studyStrong dose-response associationStudy-specific odds ratiosMultivariable logistic regression modelInternational BEACON ConsortiumDose-response associationBody mass indexCigarette smoking cessationCase-control studyWhite non-Hispanic menEsophageal Adenocarcinoma ConsortiumNon-Hispanic menLogistic regression modelsGastroesophageal refluxCohort studyCurrent smokers
1996
Estrogen Replacement Therapy and Risk of Epithelial Ovarian Cancer
Risch H. Estrogen Replacement Therapy and Risk of Epithelial Ovarian Cancer. Gynecologic Oncology 1996, 63: 254-257. PMID: 8910636, DOI: 10.1006/gyno.1996.0315.Peer-Reviewed Original ResearchConceptsEstrogen replacement therapyEpithelial ovarian cancerOvarian cancerReplacement therapyRelative oddsInvasive epithelial ovarian cancerMultivariate logistic regression analysisHistology-specific analysisNonmucinous ovarian cancerOral contraceptive usageLogistic regression analysisERT usageERT useMucinous tumorsTumor histologyMenopausal womenSerous carcinomaEndometrioid carcinomaHistologic groupsNonmucinous typeCancerCarcinomaRegression analysisPopulation controlsTherapy